Evidence Into Practice:Prescribing Selective Serotonin Reuptake Inhibitors
- 1 January 1998
- journal article
- research article
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 14 (2) , 387-391
- https://doi.org/10.1017/s0266462300012332
Abstract
This descriptive analysis examines prescribing trends of antidepressants in English primary care, providing analysis of NHS reimbursement data for groups of antidepressants between 1989 and 1994. Prescribing trends seem unaffected by the release of information on the effectiveness and costeffectiveness of antidepressant drugs. We found that simple distribution of the results of health technology assessments may not be sufficient to influence practice.Keywords
This publication has 12 references indexed in Scilit:
- Lessons from international experience in controlling pharmaceutical expenditure III: regulating industryBMJ, 1996
- Implementing findings of medical research: the Cochrane Collaboration on Effective Professional Practice.Quality and Safety in Health Care, 1995
- Benefits of new drugs are exaggeratedBMJ, 1994
- Controversies in Management: New or old antidepressants? New is betterBMJ, 1994
- Prescribing selective serotonin reuptake inhibitors as strategy for prevention of suicideBMJ, 1994
- What Price Depression?The British Journal of Psychiatry, 1994
- Measuring prescribing: the shortcomings of the itemBMJ, 1994
- Selective serotonin reuptake inhibitorsInternational Clinical Psychopharmacology, 1994
- Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.BMJ, 1993
- An Initial Evaluation of Effective Health Care Bulletins as Instruments of Effective DisseminationJournal of Management in Medicine, 1993